HOME: Home Monitoring of High-risk Pregnancies

NCT05763069 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-02-18

No results posted yet for this study

Summary

High-risk pregnancies often require long-term hospitalization or outpatient maternal and/or fetal monitoring, placing a burden on patients, hospital resources and society. The demand for intensified pregnancy surveillance and interventions is increasing, due to the increased prevalence of risk factors like obesity and advanced maternal age, as well as altered guidelines resulting in increasing labor induction rates.The main aims of the HOME study (Home monitoring of pregnancies at risk) are to assess if home monitoring of selected high-risk pregnancies for maternal and fetal wellbeing is feasible, safe (in a clinical trial), cost-efficient, and simultaneously empowers the users.

Conditions

  • Hypertensive Disorder of Pregnancy
  • Premature Preterm Rupture of Membranes
  • Preeclampsia
  • High Risk Pregnancy
  • Previous Adverse Obstetric Outcome

Interventions

OTHER

Home surveillance of pregnancies at risk

Offer women with pregnancies at risk home surveillance instaed of more frequent hospital out-patient visits and/or hospitalisation: cardiotocographia (CTG), patient measurements of CRP, temperature, blood pressure, and clinical signs of infection or severe forms of preeclampsia.

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER
  • Norwegian SIDS and Stillbirth Society

    collaborator OTHER
  • University of Oxford

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Sykehuspartner

    collaborator UNKNOWN
  • Dignio

    collaborator UNKNOWN
  • Medexa

    collaborator UNKNOWN
  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Anne Cathrine Staff, MD, PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-21
Primary Completion
2035-09-30
Completion
2040-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763069 on ClinicalTrials.gov